BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Domo
DOMO
$187M
| $54.1K | ﹤0.01% |
5,440
+2,966
| +120% | +$59.8K |
|
3352
Turning Point Brands
TPB
$1.73B
| $54K | ﹤0.01% |
2,559
+1,359
| +113% | +$31.8K |
|
|
AGNT
3353
AGNT Inc
AGNT
$752M
| $54K | ﹤0.01% |
12,756
+6,762
| +113% | +$34.4K |
|
|
ZYXI
3354
DELISTED
Zynex
ZYXI
| $53.9K | ﹤0.01% |
5,353
+2,941
| +122% | +$28.6K |
|
3355
HF Foods Group
HFFG
$97.6M
| $53.5K | ﹤0.01% |
6,375
+5,139
| +416% | +$82.2K |
|
|
SPNE
3356
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $53.2K | ﹤0.01% |
6,511
+2,714
| +71% | +$35.7K |
|
3357
Transmedics
TMDX
$3.11B
| $53.1K | ﹤0.01% |
4,395
+2,173
| +98% | +$36.4K |
|
3358
Metallus
MTUS
$892M
| $53.1K | ﹤0.01% |
16,431
+1,871
| +13% | +$10.5K |
|
|
DO
3359
DELISTED
Diamond Offshore Drilling
DO
| $53K | ﹤0.01% |
28,981
+10,521
| +57% | +$43K |
|
|
HT
3360
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $52.6K | ﹤0.01% |
14,691
+1,042
| +8% | +$11.3K |
|
|
AKRO
3361
DELISTED
Akero Therapeutics
AKRO
| $52.5K | ﹤0.01% |
2,475
+1,913
| +340% | +$41K |
|
|
FPI
3362
Farmland Partners
FPI
$425M
| $52.4K | ﹤0.01% |
8,636
+1,891
| +28% | +$12.1K |
|
3363
Fidelity D&D Bancorp
FDBC
$321M
| $52.2K | ﹤0.01% |
1,024
+463
| +83% | +$25.7K |
|
|
CPLG
3364
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $52.1K | ﹤0.01% |
13,288
+1,235
| +10% | +$9.76K |
|
3365
Allient
ALNT
$1.86B
| $52K | ﹤0.01% |
3,293
+1,770
| +116% | +$47.6K |
|
|
PWOD
3366
DELISTED
Penns Woods Bancorp
PWOD
| $52K | ﹤0.01% |
2,139
+466
| +28% | +$13.8K |
|
3367
Accuray
ARAY
$32.9M
| $52K | ﹤0.01% |
27,352
+15,023
| +122% | +$43.4K |
|
3368
RPC Inc
RES
$1.39B
| $51.9K | ﹤0.01% |
25,212
+2,306
| +10% | +$8.54K |
|
3369
Business First Bancshares
BFST
$1.05B
| $51.8K | ﹤0.01% |
3,840
+861
| +29% | +$18.7K |
|
3370
Blue Bird Corp
BLBD
$2.05B
| $51.8K | ﹤0.01% |
4,738
+1,721
| +57% | +$31.3K |
|
3371
Modine Manufacturing
MOD
$10.8B
| $51.6K | ﹤0.01% |
15,883
+2,498
| +19% | +$16.6K |
|
3372
Park-Ohio Holdings
PKOH
$718M
| $51.5K | ﹤0.01% |
2,718
+561
| +26% | +$14.8K |
|
|
UBX
3373
DELISTED
Unity Biotechnology
UBX
| $51.5K | ﹤0.01% |
887
+550
| +163% | +$34.7K |
|
3374
Immersion
IMMR
$248M
| $51.4K | ﹤0.01% |
9,597
+2,124
| +28% | +$14.7K |
|
|
RUBY
3375
DELISTED
Rubius Therapeutics, Inc
RUBY
| $51.3K | ﹤0.01% |
11,523
+6,727
| +140% | +$50K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.